Information Provided By: 
Fly News Breaks for April 11, 2019
EVH
Apr 11, 2019 | 07:15 EDT
Canaccord analyst Richard Close maintained a Buy rating and $19 price target on Evolent Health after news outlets reported that Passport Health Plan said Medicaid rates in Kentucky were finalized this week, implying a blended positive rate increase of 4.7% for PHP. Close tells investors in a research note that the "positive" news removes a recent overhang on Evolent's stock and gives him greater confidence in the company's ability to achieve 2019 guidance. He would be an aggressive buyer of the stock.
News For EVH From the Last 2 Days
There are no results for your query EVH
